Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Applied DNA Sciences Inc
NASDAQ:APDN

Watchlist Manager
Applied DNA Sciences Inc Logo
Applied DNA Sciences Inc
NASDAQ:APDN
Watchlist
Price: 3.09 USD 3%
Market Cap: $4m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
-17%
5Y
-29%
10Y
-30%
Liabilities
+
3Y
-48%
5Y
-49%
10Y
+65%
Equity
+
3Y
+7%
5Y
-17%
10Y
-42%

Balance Sheet Decomposition
Applied DNA Sciences Inc

Balance Sheet
Applied DNA Sciences Inc

Rotate your device to view
Balance Sheet
Currency: USD
Sep-2004 Sep-2005 Sep-2006 Sep-2007 Sep-2008 Sep-2009 Sep-2010 Sep-2011 Sep-2012 Sep-2013 Sep-2014 Sep-2015 Sep-2016 Sep-2017 Sep-2018 Sep-2019 Sep-2020 Sep-2021 Sep-2022 Sep-2023 Sep-2024
Assets
Cash & Cash Equivalents
0
0
1
0
0
0
0
3
1
6
1
7
4
3
2
1
8
7
15
7
6
Cash Equivalents
0
0
1
0
0
0
0
3
1
6
1
7
4
3
2
1
8
7
15
7
6
Total Receivables
0
0
0
0
0
0
0
0
0
1
1
4
6
3
1
1
0
3
3
0
0
Accounts Receivables
0
0
0
0
0
0
0
0
0
1
1
4
6
3
1
1
0
3
3
0
0
Other Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
Other Current Assets
0
0
0
1
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
0
1
Total Current Assets
0
0
1
1
0
0
0
3
1
7
2
12
11
6
4
2
9
11
20
8
8
PP&E Net
0
0
0
0
0
0
0
0
0
1
1
1
1
1
0
0
1
3
2
2
1
PP&E Gross
0
0
0
0
0
0
0
0
0
1
1
1
1
1
0
0
1
3
2
0
1
Accumulated Depreciation
0
0
0
0
0
0
0
0
0
0
1
1
1
2
2
2
2
1
2
0
4
Intangible Assets
0
9
2
2
1
1
1
0
0
0
0
2
2
1
1
1
1
0
0
3
3
Goodwill
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Note Receivable
0
0
0
0
0
0
0
0
0
0
0
2
2
0
0
0
0
0
0
0
0
Other Long-Term Assets
0
0
1
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
1
1
Other Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Assets
0
N/A
9
+10 961%
5
-49%
2
-48%
2
-24%
2
-18%
1
-6%
4
+148%
1
-62%
8
+521%
4
-58%
16
+344%
16
+0%
8
-48%
6
-31%
4
-37%
11
+218%
14
+27%
22
+54%
14
-39%
13
-6%
Liabilities
Accounts Payable
2
0
0
1
0
1
1
0
0
1
1
1
2
0
1
1
1
2
2
1
1
Accrued Liabilities
0
2
5
12
12
0
0
1
0
0
0
1
1
1
0
0
1
1
2
2
1
Short-Term Debt
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
2
0
4
1
3
2
2
4
0
0
2
0
0
0
0
0
2
0
0
0
0
Other Current Liabilities
0
0
0
0
0
0
0
0
0
0
1
0
2
0
2
1
1
0
1
0
0
Total Current Liabilities
5
3
10
14
16
3
3
4
1
1
4
3
4
1
3
2
4
3
4
3
2
Long-Term Debt
0
0
5
0
0
0
0
0
0
0
0
0
0
0
2
2
1
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
14
0
0
0
0
0
0
0
3
1
0
1
0
0
1
1
0
5
5
1
Total Liabilities
5
N/A
17
+248%
14
-14%
14
+1%
16
+11%
3
-80%
3
-7%
4
+49%
1
-87%
4
+535%
5
+32%
3
-40%
5
+74%
1
-75%
5
+276%
4
-10%
6
+28%
3
-41%
9
+183%
9
-7%
4
-58%
Equity
Common Stock
12
0
0
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
Retained Earnings
23
90
92
141
147
143
151
162
169
187
200
212
224
237
248
257
270
284
293
302
310
Additional Paid In Capital
6
82
83
128
133
141
149
160
169
191
198
224
234
244
249
256
276
295
305
307
319
Total Equity
5
N/A
7
-59%
10
-28%
12
-25%
14
-18%
2
+88%
2
+9%
1
+38%
1
N/A
5
+510%
1
N/A
13
N/A
10
-18%
7
-34%
1
-89%
1
N/A
6
N/A
11
+94%
13
+16%
5
-62%
9
+85%
Total Liabilities & Equity
0
N/A
9
+11 098%
5
-49%
2
-48%
2
-23%
2
-18%
1
-6%
4
+148%
1
-62%
8
+521%
4
-58%
16
+344%
16
+0%
8
-48%
6
-31%
4
-37%
11
+218%
14
+27%
22
+54%
14
-39%
13
-6%
Shares Outstanding
Common Shares Outstanding
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Preferred Shares Outstanding
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

See Also

Summary
APDN intrinsic value, competitors valuation, and company profile.
DCF Valuation
APDN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
APDN stock valuation using valuation multiples.
Wall Street Estimates
APDN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
APDN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 316,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.